Results 131 to 140 of about 100,411 (291)

Systemic Immunosuppression to Reduce Surgical Intervention in ANCA‐Negative Subglottic Stenosis

The Laryngoscope, EarlyView.
Idiopathic subglottic stenosis (iSGS) typically follows an indolent course managed with surgical dilatation, though a subset demonstrates aggressive, recurrent disease. In this retrospective cohort study, systemic immunosuppression significantly prolonged inter‐dilation intervals in both granulomatosis with polyangiitis‐associated SGS and an “atypical”
Guy Benshetrit, Stephen McAdoo, Romana Kuchai, Charles Pusey, Guri Sandhu, Chadwan Al‐Yaghchi   +5 more
wiley   +1 more source

Cochlear Implantation in Autoimmune Inner‐Ear Disease: Outcome and Patient‐Reported Benefit

The Laryngoscope, EarlyView.
This study demonstrates that patients with secondary autoimmune inner‐ear disease (AIED) achieve significant improvements in speech perception and quality of life following cochlear implantation. Although AIED patients may show slightly lower performance in noisy environments compared to controls, their subjective hearing benefit converges with matched
Merete Hartmann, David Oestreicher, Marc Albert Hüser, Dirk Beutner, Christian Wrobel   +4 more
wiley   +1 more source

Adverse Events Related to Azathioprine Use in Patients With Inflammatory Bowel Disease: A Real-World Cohort Study. [PDF]

Gastroenterol Res Pract
Ranjan MK, Neupane P, Maharjan B, Lamsal M, Poudel B.   +4 more
europepmc   +1 more source

Notes on some immunosuppressive agents and their use in human liver transplant recipients [PDF]

, 1974
Groth, CG, Halgrimson, CG, Husberg, B, Kashiwagi, N, Penn, I, Putnam, CW, Starzl, TE   +6 more
core  

Azathioprine as maintenance therapy for IgG4-related diseases: a retrospective case series and case-based review of the literature. [PDF]

Rheumatol Int
Reisch M, Spindelböck WJ, Hodl I, Pietsch D, Rainer F, Kickinger D, Sutic A, Thiel J, Stradner M.   +8 more
europepmc   +1 more source

Cyclophosphamide and whole organ transplantation in human beings. [PDF]

, 1971
Booth, AS, Corman, JL, Groth, CG, Halgrimson, CG, Launois, B, Martineau, G, Penn, I, Porter, KA, Putnam, CW, Schroter, GT, Starzl, TE   +10 more
core  

Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Current therapeutic management of juvenile myasthenia gravis (JMG) predominantly relies on conventional immunosuppressive therapies and expert consensus extrapolated from adult data, creating a critical gap in high‐quality, pediatric‐specific clinical evidence.
Jing Lin, Guoyan Qi, Susan Luo, Qilong Jiang, Bitao Bu, Min Liu, Yuzhen Wei, Meigui Han, Junhong Yang, Zhilan Zhao, Lili Zhang, Yifan Zhang, Haoyou Xu, Xingjie Hao, Zhijun Li   +14 more
wiley   +1 more source

Concurrent Drug-induced Rowell Syndrome and Acute Generalized Exanthematous Pustulosis. [PDF]

Acta Derm Venereol
Hsu YA, Chu KY, Lan CE.
europepmc   +1 more source

Frequent achievement of a drug-free state after orthotopic liver transplantation [PDF]

, 1993
Abu-Elmagd, K, Demetris, AJ, Fung, JJ, Nalesnik, M, Nour, B, Ramos, H, Reyes, J, Starzl, TE, Todo, S, Trucco, M, Tzakis, A, Zeevi, A   +11 more
core  

Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Myasthenia gravis (MG) is associated with thymic neoplasms. However, an increased prevalence of extrathymic neoplasms has also been reported. This study aimed to evaluate the rates of malignancy in MG patients while accounting for risk factors such as disease characteristics and immunomodulatory treatments.
Keshet Pardo, Tasneem Kab, Mark A. Hellmann, Itay Lotan, Tzippy Shochat, Nadav Loebl, Bar Yacobi, Yitzhak Friedman, Leor Perl, Nitai Shimon, Yiska Loewenberg Weisband, Liya Bieber, Eitan Auriel, Adi Wilf‐Yarkoni   +13 more
wiley   +1 more source